The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Non-Invasive Prenatal Screening (NIPS) Market Research Report 2025
Synopsis
The global Non-Invasive Prenatal Screening (NIPS) market was valued at US$ 3800 million in 2023 and is anticipated to reach US$ 7221.2 million by 2030, witnessing a CAGR of 9.6% during the forecast period 2024-2030.
Non-invasive prenatal screening (NIPS) is an emerging prenatal screening technology with many advantages, including non-invasiveness and high accuracy. As technology continues to advance and the market continues to expand, the development prospects of NIPS look very promising.
First, the market demand for NIPS is growing. With the improvement of people's health awareness and the popularization of the concept of eugenics and postnatal care, more and more pregnant women choose to undergo prenatal screening. Compared with traditional screening methods, NIPS has higher accuracy and wider applicability, so it is increasingly favored by pregnant women. At the same time, with the full liberalization of the two-child policy, the proportion of older mothers has increased significantly, and the demand for NIPS will further increase.
Secondly, NIPS technology is constantly improving. With the rapid development of gene sequencing technology, the detection accuracy and reliability of NIPS continue to improve. For example, second-generation sequencing technology (NGS) has been widely used in NIPS, which can detect multiple gene mutations simultaneously, thereby improving the accuracy and efficiency of detection. In addition, with the development of artificial intelligence and big data technology, NIPS analysis and interpretation have become more accurate and faster.
However, the development of NIPS also faces some challenges. For example, currently NIPS can only detect some common chromosomal diseases and may not provide accurate predictions for other diseases. In addition, the relatively high cost of NIPS also limits its popularity in some areas. At the same time, the supervision of the accuracy and security of NIPS also needs to be further improved.
In general, although the development of NIPS still faces some challenges, with the continuous advancement of technology and the continuous expansion of the market, its development prospects look very promising. In the future, NIPS may become one of the main means of prenatal screening and play an important role in ensuring the health of mothers and infants.
This report aims to provide a comprehensive presentation of the global market for Non-Invasive Prenatal Screening (NIPS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Prenatal Screening (NIPS).
Report Scope
The Non-Invasive Prenatal Screening (NIPS) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-Invasive Prenatal Screening (NIPS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Invasive Prenatal Screening (NIPS) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Myriad Genetics
Illumina
Progenity
Natera
Yourgene Health
Roche Sequencing Solutions (RSS)
Eurofins LifeCodexx GmbH
Labcorp
PerkinElmer
Harmony
Segment by Type
Trisomy 21
Trisomy 18
Trisomy 13
Sex Chromosome Aneuploidies
Others
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Invasive Prenatal Screening (NIPS) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Non-Invasive Prenatal Screening (NIPS) market was valued at US$ 3800 million in 2023 and is anticipated to reach US$ 7221.2 million by 2030, witnessing a CAGR of 9.6% during the forecast period 2024-2030.
Non-invasive prenatal screening (NIPS) is an emerging prenatal screening technology with many advantages, including non-invasiveness and high accuracy. As technology continues to advance and the market continues to expand, the development prospects of NIPS look very promising.
First, the market demand for NIPS is growing. With the improvement of people's health awareness and the popularization of the concept of eugenics and postnatal care, more and more pregnant women choose to undergo prenatal screening. Compared with traditional screening methods, NIPS has higher accuracy and wider applicability, so it is increasingly favored by pregnant women. At the same time, with the full liberalization of the two-child policy, the proportion of older mothers has increased significantly, and the demand for NIPS will further increase.
Secondly, NIPS technology is constantly improving. With the rapid development of gene sequencing technology, the detection accuracy and reliability of NIPS continue to improve. For example, second-generation sequencing technology (NGS) has been widely used in NIPS, which can detect multiple gene mutations simultaneously, thereby improving the accuracy and efficiency of detection. In addition, with the development of artificial intelligence and big data technology, NIPS analysis and interpretation have become more accurate and faster.
However, the development of NIPS also faces some challenges. For example, currently NIPS can only detect some common chromosomal diseases and may not provide accurate predictions for other diseases. In addition, the relatively high cost of NIPS also limits its popularity in some areas. At the same time, the supervision of the accuracy and security of NIPS also needs to be further improved.
In general, although the development of NIPS still faces some challenges, with the continuous advancement of technology and the continuous expansion of the market, its development prospects look very promising. In the future, NIPS may become one of the main means of prenatal screening and play an important role in ensuring the health of mothers and infants.
This report aims to provide a comprehensive presentation of the global market for Non-Invasive Prenatal Screening (NIPS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Prenatal Screening (NIPS).
Report Scope
The Non-Invasive Prenatal Screening (NIPS) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-Invasive Prenatal Screening (NIPS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Invasive Prenatal Screening (NIPS) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Myriad Genetics
Illumina
Progenity
Natera
Yourgene Health
Roche Sequencing Solutions (RSS)
Eurofins LifeCodexx GmbH
Labcorp
PerkinElmer
Harmony
Segment by Type
Trisomy 21
Trisomy 18
Trisomy 13
Sex Chromosome Aneuploidies
Others
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Invasive Prenatal Screening (NIPS) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Trisomy 21
1.2.3 Trisomy 18
1.2.4 Trisomy 13
1.2.5 Sex Chromosome Aneuploidies
1.2.6 Others
1.3 Market by Application
1.3.1 Global Non-Invasive Prenatal Screening (NIPS) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-Invasive Prenatal Screening (NIPS) Market Perspective (2019-2030)
2.2 Non-Invasive Prenatal Screening (NIPS) Growth Trends by Region
2.2.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Non-Invasive Prenatal Screening (NIPS) Historic Market Size by Region (2019-2024)
2.2.3 Non-Invasive Prenatal Screening (NIPS) Forecasted Market Size by Region (2025-2030)
2.3 Non-Invasive Prenatal Screening (NIPS) Market Dynamics
2.3.1 Non-Invasive Prenatal Screening (NIPS) Industry Trends
2.3.2 Non-Invasive Prenatal Screening (NIPS) Market Drivers
2.3.3 Non-Invasive Prenatal Screening (NIPS) Market Challenges
2.3.4 Non-Invasive Prenatal Screening (NIPS) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Invasive Prenatal Screening (NIPS) Players by Revenue
3.1.1 Global Top Non-Invasive Prenatal Screening (NIPS) Players by Revenue (2019-2024)
3.1.2 Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Players (2019-2024)
3.2 Global Non-Invasive Prenatal Screening (NIPS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-Invasive Prenatal Screening (NIPS) Revenue
3.4 Global Non-Invasive Prenatal Screening (NIPS) Market Concentration Ratio
3.4.1 Global Non-Invasive Prenatal Screening (NIPS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Invasive Prenatal Screening (NIPS) Revenue in 2023
3.5 Non-Invasive Prenatal Screening (NIPS) Key Players Head office and Area Served
3.6 Key Players Non-Invasive Prenatal Screening (NIPS) Product Solution and Service
3.7 Date of Enter into Non-Invasive Prenatal Screening (NIPS) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Invasive Prenatal Screening (NIPS) Breakdown Data by Type
4.1 Global Non-Invasive Prenatal Screening (NIPS) Historic Market Size by Type (2019-2024)
4.2 Global Non-Invasive Prenatal Screening (NIPS) Forecasted Market Size by Type (2025-2030)
5 Non-Invasive Prenatal Screening (NIPS) Breakdown Data by Application
5.1 Global Non-Invasive Prenatal Screening (NIPS) Historic Market Size by Application (2019-2024)
5.2 Global Non-Invasive Prenatal Screening (NIPS) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Non-Invasive Prenatal Screening (NIPS) Market Size (2019-2030)
6.2 North America Non-Invasive Prenatal Screening (NIPS) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2019-2024)
6.4 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non-Invasive Prenatal Screening (NIPS) Market Size (2019-2030)
7.2 Europe Non-Invasive Prenatal Screening (NIPS) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2019-2024)
7.4 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size (2019-2030)
8.2 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2019-2024)
8.4 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non-Invasive Prenatal Screening (NIPS) Market Size (2019-2030)
9.2 Latin America Non-Invasive Prenatal Screening (NIPS) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2019-2024)
9.4 Latin America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size (2019-2030)
10.2 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2019-2024)
10.4 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Myriad Genetics
11.1.1 Myriad Genetics Company Detail
11.1.2 Myriad Genetics Business Overview
11.1.3 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Introduction
11.1.4 Myriad Genetics Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024)
11.1.5 Myriad Genetics Recent Development
11.2 Illumina
11.2.1 Illumina Company Detail
11.2.2 Illumina Business Overview
11.2.3 Illumina Non-Invasive Prenatal Screening (NIPS) Introduction
11.2.4 Illumina Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024)
11.2.5 Illumina Recent Development
11.3 Progenity
11.3.1 Progenity Company Detail
11.3.2 Progenity Business Overview
11.3.3 Progenity Non-Invasive Prenatal Screening (NIPS) Introduction
11.3.4 Progenity Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024)
11.3.5 Progenity Recent Development
11.4 Natera
11.4.1 Natera Company Detail
11.4.2 Natera Business Overview
11.4.3 Natera Non-Invasive Prenatal Screening (NIPS) Introduction
11.4.4 Natera Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024)
11.4.5 Natera Recent Development
11.5 Yourgene Health
11.5.1 Yourgene Health Company Detail
11.5.2 Yourgene Health Business Overview
11.5.3 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Introduction
11.5.4 Yourgene Health Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024)
11.5.5 Yourgene Health Recent Development
11.6 Roche Sequencing Solutions (RSS)
11.6.1 Roche Sequencing Solutions (RSS) Company Detail
11.6.2 Roche Sequencing Solutions (RSS) Business Overview
11.6.3 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Introduction
11.6.4 Roche Sequencing Solutions (RSS) Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024)
11.6.5 Roche Sequencing Solutions (RSS) Recent Development
11.7 Eurofins LifeCodexx GmbH
11.7.1 Eurofins LifeCodexx GmbH Company Detail
11.7.2 Eurofins LifeCodexx GmbH Business Overview
11.7.3 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Introduction
11.7.4 Eurofins LifeCodexx GmbH Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024)
11.7.5 Eurofins LifeCodexx GmbH Recent Development
11.8 Labcorp
11.8.1 Labcorp Company Detail
11.8.2 Labcorp Business Overview
11.8.3 Labcorp Non-Invasive Prenatal Screening (NIPS) Introduction
11.8.4 Labcorp Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024)
11.8.5 Labcorp Recent Development
11.9 PerkinElmer
11.9.1 PerkinElmer Company Detail
11.9.2 PerkinElmer Business Overview
11.9.3 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Introduction
11.9.4 PerkinElmer Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024)
11.9.5 PerkinElmer Recent Development
11.10 Harmony
11.10.1 Harmony Company Detail
11.10.2 Harmony Business Overview
11.10.3 Harmony Non-Invasive Prenatal Screening (NIPS) Introduction
11.10.4 Harmony Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024)
11.10.5 Harmony Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Trisomy 21
Table 3. Key Players of Trisomy 18
Table 4. Key Players of Trisomy 13
Table 5. Key Players of Sex Chromosome Aneuploidies
Table 6. Key Players of Others
Table 7. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Region (2019-2024)
Table 11. Global Non-Invasive Prenatal Screening (NIPS) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Region (2025-2030)
Table 13. Non-Invasive Prenatal Screening (NIPS) Market Trends
Table 14. Non-Invasive Prenatal Screening (NIPS) Market Drivers
Table 15. Non-Invasive Prenatal Screening (NIPS) Market Challenges
Table 16. Non-Invasive Prenatal Screening (NIPS) Market Restraints
Table 17. Global Non-Invasive Prenatal Screening (NIPS) Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Players (2019-2024)
Table 19. Global Top Non-Invasive Prenatal Screening (NIPS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Screening (NIPS) as of 2023)
Table 20. Ranking of Global Top Non-Invasive Prenatal Screening (NIPS) Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Non-Invasive Prenatal Screening (NIPS) Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Non-Invasive Prenatal Screening (NIPS) Product Solution and Service
Table 24. Date of Enter into Non-Invasive Prenatal Screening (NIPS) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Type (2019-2024)
Table 28. Global Non-Invasive Prenatal Screening (NIPS) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Type (2025-2030)
Table 30. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Application (2019-2024)
Table 32. Global Non-Invasive Prenatal Screening (NIPS) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Application (2025-2030)
Table 34. North America Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2025-2030) & (US$ Million)
Table 49. Myriad Genetics Company Detail
Table 50. Myriad Genetics Business Overview
Table 51. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product
Table 52. Myriad Genetics Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024) & (US$ Million)
Table 53. Myriad Genetics Recent Development
Table 54. Illumina Company Detail
Table 55. Illumina Business Overview
Table 56. Illumina Non-Invasive Prenatal Screening (NIPS) Product
Table 57. Illumina Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024) & (US$ Million)
Table 58. Illumina Recent Development
Table 59. Progenity Company Detail
Table 60. Progenity Business Overview
Table 61. Progenity Non-Invasive Prenatal Screening (NIPS) Product
Table 62. Progenity Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024) & (US$ Million)
Table 63. Progenity Recent Development
Table 64. Natera Company Detail
Table 65. Natera Business Overview
Table 66. Natera Non-Invasive Prenatal Screening (NIPS) Product
Table 67. Natera Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024) & (US$ Million)
Table 68. Natera Recent Development
Table 69. Yourgene Health Company Detail
Table 70. Yourgene Health Business Overview
Table 71. Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product
Table 72. Yourgene Health Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024) & (US$ Million)
Table 73. Yourgene Health Recent Development
Table 74. Roche Sequencing Solutions (RSS) Company Detail
Table 75. Roche Sequencing Solutions (RSS) Business Overview
Table 76. Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product
Table 77. Roche Sequencing Solutions (RSS) Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024) & (US$ Million)
Table 78. Roche Sequencing Solutions (RSS) Recent Development
Table 79. Eurofins LifeCodexx GmbH Company Detail
Table 80. Eurofins LifeCodexx GmbH Business Overview
Table 81. Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product
Table 82. Eurofins LifeCodexx GmbH Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024) & (US$ Million)
Table 83. Eurofins LifeCodexx GmbH Recent Development
Table 84. Labcorp Company Detail
Table 85. Labcorp Business Overview
Table 86. Labcorp Non-Invasive Prenatal Screening (NIPS) Product
Table 87. Labcorp Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024) & (US$ Million)
Table 88. Labcorp Recent Development
Table 89. PerkinElmer Company Detail
Table 90. PerkinElmer Business Overview
Table 91. PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product
Table 92. PerkinElmer Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024) & (US$ Million)
Table 93. PerkinElmer Recent Development
Table 94. Harmony Company Detail
Table 95. Harmony Business Overview
Table 96. Harmony Non-Invasive Prenatal Screening (NIPS) Product
Table 97. Harmony Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024) & (US$ Million)
Table 98. Harmony Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Invasive Prenatal Screening (NIPS) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Type: 2023 VS 2030
Figure 3. Trisomy 21 Features
Figure 4. Trisomy 18 Features
Figure 5. Trisomy 13 Features
Figure 6. Sex Chromosome Aneuploidies Features
Figure 7. Others Features
Figure 8. Global Non-Invasive Prenatal Screening (NIPS) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Application: 2023 VS 2030
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Non-Invasive Prenatal Screening (NIPS) Report Years Considered
Figure 13. Global Non-Invasive Prenatal Screening (NIPS) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Non-Invasive Prenatal Screening (NIPS) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Region: 2023 VS 2030
Figure 16. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Players in 2023
Figure 17. Global Top Non-Invasive Prenatal Screening (NIPS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Screening (NIPS) as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Non-Invasive Prenatal Screening (NIPS) Revenue in 2023
Figure 19. North America Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2019-2030)
Figure 21. United States Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2019-2030)
Figure 25. Germany Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Share by Region (2019-2030)
Figure 33. China Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2019-2030)
Figure 41. Mexico Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2019-2030)
Figure 45. Turkey Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Myriad Genetics Revenue Growth Rate in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024)
Figure 48. Illumina Revenue Growth Rate in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024)
Figure 49. Progenity Revenue Growth Rate in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024)
Figure 50. Natera Revenue Growth Rate in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024)
Figure 51. Yourgene Health Revenue Growth Rate in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024)
Figure 52. Roche Sequencing Solutions (RSS) Revenue Growth Rate in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024)
Figure 53. Eurofins LifeCodexx GmbH Revenue Growth Rate in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024)
Figure 54. Labcorp Revenue Growth Rate in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024)
Figure 55. PerkinElmer Revenue Growth Rate in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024)
Figure 56. Harmony Revenue Growth Rate in Non-Invasive Prenatal Screening (NIPS) Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
